Caitong International Asset Management »

Monte Rosa Therapeutics shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 1.4k 15.68
2025-06-30 $4.8k 1.1k 4.51

More positions owned by Caitong International Asset Management

Axsome Therapeutics (AXSM)
Satellogic Com Cl A (SATL)
American Bitcoin Corp. Com Cl A (ABTC)
Ultragenyx Pharmaceutical (RARE)
Redwire Corporation (RDW)
Corcept Therapeutics Incorporated (CORT)
Ur-energy (URG)
Dynavax Technologies Corp Com New (DVAX)
Arbe Robotics Ordinary Shares (ARBE)
T1 Energy Com New (TE)
Warby Parker Cl A Com (WRBY)
Petroleo Brasileiro Sa Petro Sp Adr Non Vtg (PBR.A)
Core Scientific (CORZ)
Planet Labs Pbc Com Cl A (PL)
Klarna Group SHS (KLAR)

View all positions for Caitong International Asset Management

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BVF
Baker Bros. Advisors
TCG Crossover Management
Versant Venture Management
BlackRock
Suvretta Capital Management
Vanguard Group
FMR
State Street Corporation
Aisling Capital Management
American Century Companies
Geode Capital Management
MPM Oncology Impact Management
Silverarc Capital Management

View all funds holding Monte Rosa Therapeutics